Observational study of cenegermin for the treatment of limbal stem cell deficiency associated with neurotrophic keratopathy.

Therapeutic advances in ophthalmology（2022）

引用 0|浏览5

暂无评分

摘要

The study was registered at ClinicalTrials.gov with identifier NCT04552730 (https://clinicaltrials.gov/ct2/show/NCT04552730).

查看译文

关键词

cenegermin,limbal stem cell deficiency,neurotrophic keratopathy,oxervate

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要